Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?

16 days until earnings call

Profile

Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
707.8M
P/E Ratio
N/A
Total Cash
178.58M
Projected Growth
N/A
Total Debt
2.21M
Revenue
7.84M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
3.43
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price

Fundamentals

STOK
Capitalization
708M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
179M
Total Cash/Share
3.43
Total Debt
2.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
7.84M
ROE
N/A
Book Value
140M
P/B Ratio
5.04
Cash Flow
N/A
Earnings
-2.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
5.43
Current Revenue Per Employee
38327.27
Dividends Per Share - Security
N/A
EBITDA
-116.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.57
Shares Held By Institutions
815M
Shares Outstanding - Current
52.1M
Total Liabilities
64.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
158.175
View a ticker or compare two or three
STOK
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com